Balance Sheet

Accounts Payables Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Sanofi (SNY) Treasury Shares (2021)

Sanofi's Treasury Shares history spans 4 years, with the latest figure at -$839.4 million for Q2 2021.

On a quarterly basis, Treasury Shares changed N/A to -$839.4 million in Q2 2021 year-over-year; TTM through Jun 2021 was -$839.4 million, a N/A change, with the full-year FY2015 number at -$331.0 million, changed N/A from a year prior.
Treasury Shares hit -$839.4 million in Q2 2021 for Sanofi, down from -$326.6 million in the prior quarter.
Over the last five years, Treasury Shares for SNY hit a ceiling of -$839.4 million in Q2 2021 and a floor of -$839.4 million in Q2 2021.